Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

07/05/2021 08:30

May 7 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2021        Jun 30, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               3.27                5.77             22.00    
  Operating       loss 190 mln            2.76              4.50    
  Recurring       loss 232 mln            2.70              4.40    
  Net             loss 147 mln            1.87              3.10    
  EPS             loss 3.39 yen         43.56 yen        71.57 yen  
  EPS Diluted                           43.28 yen                   
  Ann Div                               25.00 yen        20.00 yen  
  -Q2 div                               7.00 yen         7.00 yen   
  -Q4 div                               18.00 yen        13.00 yen  
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T